Helping Cancer Cells Die
One of the genes that helps to keep cancer from ever forming is the p53 gene. It works by blocking cancer cells from killing themselves. When p53 is messed up in some way, cancer cells go to town and wreak havoc.
Chronic Myelogenous Leukemia Drug Approved
Pfizer Inc. announced the US Food and Drug Administration (FDA) has approved BOSULIF (bosutinib), an Abl and Src kinase inhibitor, for the treatment of adult patients with chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
AIDS and Cancer Links
People living with HIV (human immunodeficiency virus) are at greater risk of various forms of cancer. In fact, when these cancers appear, it means the virus has turned into full-blown AIDS (acquired immunodeficiency syndrome).
New Chronic Myeloid Leukemia Drug
Chronic myeloid leukemia often responds to first-line treatment. Gleevec ( imatinib ) is the standard first-line medication. The disease usually quiets for a time, then comes back. A new drug has been approved to treat this blood and bone marrow cancer.
Drug to Decrease Chemo Side Effects Approved
Chemotherapy can hurt the body’s ability to fight off infection. The cancer-killing medicines lower the number of infection-fighting white blood cells. The condition is called neutropenia and another option is now available to treat it.
Monitoring the Monitoring of CML Patients
When monitored and managed properly, the outlook is quite good for people living with chronic myeloid leukemia ( CML ). There are three targeted therapies that are effective in controlling this disease. One of the keys to success is close monitoring.
New Genetic Signature for Leukemia
So what’s a genetic signature you ask? Basically it’s a set of genes in a cell that are involved in how disease starts, grows and spreads. This is hugely complicated and exciting science.
Rare Leukemia Rx Approved
Marqibo ( vincristine sulfate liposome injection) has been approved by the U.S. Food and Drug Administration to treat adults with a rare type of leukemia called Philadelphia chromosome negative ( Ph -) acute lymphoblastic leukemia (ALL).
Young People with Chronic Myeloid Leukemia
Since targeted therapies known as tyrosine kinase inhibitors (TKI) have been in use, the outlook for people diagnosed with chronic myeloid leukemia has improved dramatically. Unfortunately, this trend isn't true for all patients.
Childhood Leukemia and Fertility Rx
Roughly one percent of the 4 million children born in the U.S. every year are conceived through in vitro fertilization ( IVF ). According to the CDC, just over 47,000 IVF children were born in 2010.